Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11977 | Mcl1-IN-9 | BCL | Apoptosis |
Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) Inhibitor with an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM. | |||
T79404 |
A09-003
|
Apoptosis; BCL; CDK | Apoptosis; Cell Cycle/Checkpoint |
A09-003 是一种新型细胞周期蛋白依赖性激酶-9 CDK-9 抑制剂。A09-003 能够抑制多种白血病细胞系的增殖,抑制hi髓系细胞白血病序列-1蛋白增加。A09-003还能诱导细胞凋亡,降低 RNA 聚合酶 II 活性,降低 Mcl-1 表达。 | |||
T79242 |
Mcl-1 inhibitor 16
|
||
Mcl-1 inhibitor16 (Compound 9)为基于铂的线粒体靶向性Mcl-1抑制剂。该化合物通过诱导Bax/Bak依赖的细胞凋亡(apoptosis),展现出对癌细胞的作用,可以单独使用或与ABT-199联合应用,表现出抗肿瘤活性。 | |||
T70988 |
Ibulocydine
|
||
Ibulocydine is a potent CDK inhibitor. Ibulocydine has high activity against Cdk7/cyclin H/Mat1 and Cdk9/cyclin T. Ibulocydine inhibited the growth of HCC cells more effectively than other Cdk inhibitors, including olomoucine and roscovitine, whereas ibulocydine as well as the other Cdk inhibitors and BMK-Y101 minimally influenced the growth of normal hepatocyte cells. Ibulocydine induced apoptosis in HCC cells, most likely by inhibiting Cdk7 and Cdk9. In vitro treatment of HCC cells with ibuloc... | |||
T29060 |
UNBS-1450
UNBS 1450,UBS1450,UBS-1450,UBS 1450 |
||
UNBS-1450 is a sodium channel antagonist. UNBS-1450 is a hemi-synthetic cardenolide derived from 2″-oxovorusharin, it is effective against various cancer cell types with an excellent differential toxicity. At low nanomolar concentrations, UNBS-1450 induce |